The Netherlands: In the midst of change

  At the World Pharma Pricing & Market Access Congress 2014 conference,┬áDr Martin van der Graaff, Secretary, Reimbursement Committee, CVZ gave the presentation: “The Netherlands: In the mi(d)st of change” Download and learn: Organisational change in CVZ End of an era: Policy rules and outcomes research First results and experiences with CED Preliminary criteria for prioritizing inpatient drugs Priorities Are …

Effective development and implementation of a compliance programme

Kristine Aachmann Bethe, Corporate Counsel, Business Ethics Compliance Office, Novo Nordisk A/S just gave a presentation this morning at Pharma Compliance 2013 on the effective development and implementation of a compliance programme.  Her presentation began by highlighting why compliance is so important to Novo Nordisk, explaining that now, as part of big pharma, there are increased demands and expectations to …

India Industry wants govt to enforce SCM standards for dry pharma products

Even dry pharma based cargo should be transported only under strict temperature controlled environment It is a common mis-conception by the industry that dry pharma products do not require any regulations. Although dry pharma products need not be transported under an extremely temperature-regulated environment, it is still crucial that a minimal level of regulation is maintained. Doing so would not …

Generics key to improving Australian economy

Government should support generics industry Both the Medical Journal of Australia and the Australian Generic Medicines Industry Association are in agreement that the government could make substantial savings by adopting policies that promote the usage of lower cost generic medicines, the pharma letter recently reported. Basic requirements to capitalise on these savings are for generics to be prescribed more often, …